Warning and Advisories for Healthcare Providers
>
Letters to Healthcare Providers
Letters to Healthcare Providers
Finasteride: Assessing the potential risks of suicide, suicidal thoughts (suicidal ideation) and self-injury (Letter to Healthcare Professionals)
Attachment:
Finasteride: Assessing the potential risks of suicide, suicidal thoughts (suicidal ideation) and self-injury
Related Information:
Measures to minimise risk of suicidal thoughts with finasteride and dutasteride ...
Posted 2025-05-09
European Union: Measures to minimise risk of suicidal thoughts with finasteride ...
Posted 2025-05-09
European Union: EMA has started a review of medicinal products containing finast...
Posted 2024-10-05
The United Kingdom: Finasteride reminder of the risk psychiatric side effects an...
Posted 2024-04-30
Canada: Summary Safety Review: Finasteride: Assessing the potential risks of sui...
Posted 2023-01-20
Singapore: Finasteride and potential risk of suicidal ideation
Posted 2022-08-31
Canada: Summary Safety Review - Proscar and Propecia (finasteride) - Assessing t...
Posted 2019-02-27
The United Kingdom: Finasteride: rare reports of depression and suicidal thought...
Posted 2017-05-25
Finasteride: rare reports of depression and suicidal thoughts (Letter to Healthc...
Posted 2017-05-25